Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2010 Apr 1.

Published in final edited form as: Gynecol Oncol. 2009 Jan 21;113(1):21–27. doi: 10.1016/j.ygyno.2008.12.003

Table 2.

Outcome statistics

	Relapse within 0-6 months (n = 16)	Relapse within 6-12 months (n = 9)	Total (n = 25)
Overall response	1 (6.3%)	0	1 (4%)
Stable disease	5 (31.3%)	4 (44.4%)	9 (36%)
Progression-free survival
Median, months	1.6 (1.3-2.7)^a	2.1 (1.4-2.6)^a	1.8 (1.3-2.6)^a
@ 4 months	4 (25%)	1 (11.1%)	5 (20%)
@ 6 months	3 (18.8%)	0	3 (12%)
@ 12 months	0	0	0
Overall survival
Median, months	8.2 (5.6-NR^b)^a	NR^b (13.6-NR^b)^a	13 (5.6-NR^b)^a
@ 4 months	14 (87.5%)	9 (100%)	23 (92%)
@ 6 months	10 (62.5%)	9 (100%)	19 (76%)
@ 12 months	3 (37.5%)	7 (77.8%)	10 (40%)

^a

95% confidence interval.

^b

NR = not reached.